Regular versus as-needed short-acting inhaled β-agonist therapy for chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 1, 2001, Pages 85-90

  Cook, Deborah ^a,b   Guyatt, Gordon ^c   Wong, Eric ^c   Goldstein, Roger ^c   Bedard, Michel ^c   Austin, Peggy ^c   Ramsdale, Helen ^c   Jaeschke, Roman ^c   Sears, Malcolm ^c  

^a ST JOSEPH S HOSPITAL   (Canada)

^b CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG USE; DYSPNEA; EMOTIONAL STABILITY; EXERCISE TEST; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SMOKING; SYMPTOMATOLOGY; VITAL CAPACITY;

EID: 0035152065     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.1.2004214     Document Type: Article

References (38)

1. International comparisons in COPD mortality
2. COPD: A disease of reversible air flow obstruction
3. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence
4. Bronchodilator response in chronic obstructive pulmonary disease
5. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible airflow obstruction
6. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction
7. Bronchodilators in chronic airflow limitation, effects on airway function, exercise capacity and quality of life
8. Role of parasympathetic system in airway obstruction due to emphysema
9. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction
10. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation
11. Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction
12. High dose salbutamol in chronic bronchitis: Comparison of 400 μg, 1 mg, and 2 mg and placebo delivered by rotahaler
13. The effect of increasing doses of beta-agonists on spirometry, exercise capacity, and quality of life in patients with chronic airflow limitation
14. Regular inhaled beta-agonist treatment in bronchial asthma
15. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma
16. Regular versus as-needed inhaled salbutamol in asthma control
17. Regular inhaled salbutamoI and asthma control: The TRUST randomized trial
18. Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on demand? A randomized controlled study
19. Continuous and on-demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: Four-year follow-up randomized controlled study
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma
21. Standardization of spirometry
22. How should we measure function in patients with chronic heart and lung disease?
23. Effect of encouragement on walking test performance
24. Quality of life in patients with chronic airflow limitation
25. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results of the medical outcomes study
26. Measurement of health status: Ascertaining the meaning of a change in quality-of-life questionnaire score
27. Determining a minimal important change in a disease-specific quality of life questionnaire
28. Interpretation of rhinoconjunctivitis quality of life questionnaire data
29. Pharmacologic therapy of obstructive airway disease
30. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease
31. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective then either agent alone - An 85 day multicenter study
32. Efficacy of salmeterol Xinafoate in the treatment of COPD
33. Clinical usefulness of N of 1 randomized control trials: Three year experience
34. Clinical usefulness of N of 1 RCTs in patients with chronic airflow limitation
35. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
36. Guidelines for the assessment and management of chronic obstructive pulmonary disease
37. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease